Skip to main content
OpenTrials

Clinical trial condition

Coronaviridae Infections

Explore clinical trials studying Coronaviridae Infections. Study availability and eligibility vary by location and protocol.

5,124 public trials 292 recruiting studies
Refine in advanced search Browse all conditions

Coronaviridae Infections trial results

Completed

A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19

NCT05713318

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • Beijing Ditan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital,Capital Medical University Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Mengchao Hepatobiliary Hospital Of Fujian Medical University Fuzhou, Fujian, China
View all 16 locations
View Trial Details
Completed

Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years

NCT04895982

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Ochsner Clinic Foundation Jefferson, Louisiana, United States
  • Ochsner Medical Center - Jefferson Highway Jefferson, Louisiana, United States
  • Ochsner Clinic Foundation Kenner, Louisiana, United States
  • Ochsner Medical Center Kenner Kenner, Louisiana, United States
View all 29 locations
View Trial Details
Completed

A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized

NCT05799495

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Cullman Clinical Trials Cullman, Alabama, United States
  • ClinMed Phoenix, Arizona, United States
  • Epic Medical Research - Surprise Surprise, Arizona, United States
  • Applied Research Center of Arkansas Little Rock, Arkansas, United States
View all 53 locations
View Trial Details
Completed

A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

NCT05567952

Conditions
COVID-19, COVID-19 rebound, Coronaviridae Infections, +10 more
Locations
  • The Institute for Liver Health dba Arizona Clinical Trials Mesa, Arizona, United States
  • Abby's Research institute Phoenix, Arizona, United States
  • Epic Medical Research - Surprise Surprise, Arizona, United States
  • Smart Cures Clinical Research Anaheim, California, United States
View all 84 locations
View Trial Details

Related conditions